Skip to main content
. Author manuscript; available in PMC: 2015 May 6.
Published in final edited form as: J Am Coll Cardiol. 2014 Jan 8;63(17):1796–1803. doi: 10.1016/j.jacc.2013.10.085

Table 4.

30-Day/In-Hospital Adverse Events

Complication Pre-TASP (n = 56) TASP (n = 72) p Value
Reoperation for bleeding 11 (19.6) 3 (4.2) 0.005
Delayed sternal closure 6 (10.7) 1 (1.4) 0.02
Deep sternal wound infection 2 (3.6) 2 (2.8) 0.80
Acute renal failure (Cr >2.0 mg/dl and >2 × baseline) 15 (26.8) 12 (16.7) 0.16
New-onset dialysis 4 (7.1) 4 (5.6) 0.71
Prolonged ventilation (> 24 h) 16 (28.6) 15 (20.8) 0.31
Tracheostomy 5 (8.9) 6 (8.3) 0.91
Myocardial infarction 1 (1.8) 1 (1.4) 0.86
Stroke (neurologic deficit lasting >72 h) 7 (12.5) 4 (5.6) 0.16
Post-operative length of stay, days 10 ± 12 (0–55) 12 ± 12 (4–69) 0.05
30-day/in-hospital death 19 (33.9) 2 (2.8) <0.0001

Values are mean ± SD (range) or n (%).

Cr = creatinine; other abbreviation as in Table 1.